GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Digicann Ventures Inc (XCNQ:DCNN) » Definitions » ROE % Adjusted to Book Value

Digicann Ventures (XCNQ:DCNN) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Digicann Ventures ROE % Adjusted to Book Value?

Digicann Ventures's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Digicann Ventures's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Digicann Ventures's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


Digicann Ventures ROE % Adjusted to Book Value Historical Data

The historical data trend for Digicann Ventures's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Digicann Ventures ROE % Adjusted to Book Value Chart

Digicann Ventures Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -157.46 -32.95 -106.33 - Negative Equity

Digicann Ventures Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity Negative Equity Negative Equity Negative Equity -

Competitive Comparison of Digicann Ventures's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Digicann Ventures's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Digicann Ventures's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Digicann Ventures's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Digicann Ventures's ROE % Adjusted to Book Value falls into.



Digicann Ventures ROE % Adjusted to Book Value Calculation

Digicann Ventures's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

Digicann Ventures's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Digicann Ventures ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Digicann Ventures's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Digicann Ventures (XCNQ:DCNN) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C1H2
Digicann Ventures Inc Formerly Agra Ventures Ltd is a pharmaceutical company engaged in the sale of cannabis-related products. The company's geographic segment includes Germany and Canada, with the majority of sales coming from Germany.
Executives
Nicholas Jonathan Kuzyk Director, Senior Officer

Digicann Ventures (XCNQ:DCNN) Headlines

No Headlines